Neurodon Awarded Nearly $3 Million from NIH to Advance its Drug for Alzheimer’s Disease

Neurodon announced today that it has been awarded approximately $2.9 million in continued funding under its Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).

Scroll to Top